In addition, multiple factors analysis also showed that BRCA1, FAT1, CCND1, PTPN11, and ARID1A gene mutations are key genes to determine prognosis in RCC patients (Fig. 7). This evidence concerns the gene BRCA1 and renal cell carcinoma.